Jade Biosciences, Inc. (JBIO) — Financial Flexibility Index
Jade Biosciences, Inc. (JBIO) has a Financial Flexibility Index of -1.36x as of June 2026. Free cash flow of $-43.66 Million (operating CF $-43.66 Million minus capex $0.00) represents -1% of total liabilities ($32.20 Million). Check tangible net worth ratio of Jade Biosciences, Inc. to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jade Biosciences, Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Jade Biosciences, Inc. across 6 annual periods. For the full cash flow conversion analysis, see Jade Biosciences, Inc. cash conversion from operations.
Annual Financial Flexibility Index for Jade Biosciences, Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Jade Biosciences, Inc.. Explore JBIO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.47x | $-94.49 Million | $-94.69 Million | $17.26 Million | ▲ +70.0% |
| 2024 | -18.26x | $-71.20 Million | $-71.20 Million | $3.90 Million | ▼ -479.3% |
| 2023 | -3.15x | $-56.64 Million | $-56.78 Million | $17.96 Million | ▲ +30.7% |
| 2022 | -4.55x | $-38.93 Million | $-39.12 Million | $8.56 Million | ▲ +50.8% |
| 2021 | -9.24x | $-27.22 Million | $-27.40 Million | $2.94 Million | ▼ -108.6% |
| 2020 | -4.43x | $-7.86 Million | $-7.86 Million | $1.77 Million | — |